Levetiracetam is an effective add-on therapy for refractory partial-onset epilepsy when assessed by seizure-free days

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1418, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy

By Sheehy Odile

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 493-503

Adis International

Access to resources Recommend Favorite

Lacosamide first therapy for partial-onset epilepsy in 3 years

Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Add-on levetiracetam beneficial in poorly controlled epilepsy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 279, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Trial

By Lu Yang Xiao Zhanqin

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 221-229

Adis International

Access to resources Recommend Favorite

Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy

By Deeks Emma D.

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 887-900

Adis International

Access to resources Recommend Favorite